2016
DOI: 10.1016/j.neulet.2016.01.006
|View full text |Cite
|
Sign up to set email alerts
|

The influence of dizocilpine on the reserpine-induced behavioral and neurobiological changes in rats

Abstract: Clinical studies have demonstrated that a single dose of ketamine produces complete remission within 24h in some depression patients. The ability of ketamine to produce fast-acting antidepressant-like effects in animal models depends on rapid synthesis of brain-derived neurotrophic factor (BDNF). Here we examined effects of a single dose dizocilpine, a non-competitive NMDA receptor antagonist, on the behavioral and neurobiological changes in rats treated with a single high dose reserpine, which is a monoamine … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…Depression is a common psychiatric disorder, widely spread in the population, and results in decreased quality of life, and thus, treating depression is a crucial issue. 1 Although the mechanisms underlying the depression etiology remain to be elucidated, accumulating evidence support that monoamine theory is associated with depression pathophysiology. According to this theory, depression is related to reduced cerebral concentrations of one or more of the monoamines; serotonin, dopamine, and noradrenaline that are involved in maintaining psychic tone at the central level.…”
Section: Introductionmentioning
confidence: 99%
“…Depression is a common psychiatric disorder, widely spread in the population, and results in decreased quality of life, and thus, treating depression is a crucial issue. 1 Although the mechanisms underlying the depression etiology remain to be elucidated, accumulating evidence support that monoamine theory is associated with depression pathophysiology. According to this theory, depression is related to reduced cerebral concentrations of one or more of the monoamines; serotonin, dopamine, and noradrenaline that are involved in maintaining psychic tone at the central level.…”
Section: Introductionmentioning
confidence: 99%
“…In the conclusion of Munro's study, he pointed out the fact that any of such induced depression experiment should not rely on a single behavior test such as forced swimming test (FST), as this would not be sufficient to solidify a depression model [30] . Gao et al [31] observed that the rats treated with Reserpine traveled the shortest distance in comparison to the control group (saline) in the open field test. Xu et al [24] examined the depressionpain dyad in mice induced by Reserpine and found a substantial increase in the Substance P levels of the Reserpine treated groups in comparison to that in the control group.…”
Section: Observation Of Depressive Behavior and Experimental Model Tementioning
confidence: 99%
“…Hanff et al [1] , Liu et al [2] , Minor and Hanff [4] , Freitas et al [16] , Ponzio et al [18] , Arora and Chopra [22] , Li et al [32] , Sheppard and Zimmerman [46] Drug Discovery Utilizing the depletion of monoamines for a depressive model that could be reversed by potential antidepressants Liu et al [2] , Khadrawy et al [17] , Antkiewicz-Michaluk et al [21] , Xu et al [24] , Klein et al [25] , Gao et al [31] , Li et al [32] , Ozerov et al [35] , Arora et al [36] , Dhir et al [37] , Mahesh et al [38] ,…”
Section: Research Application Molecular Mechanism Relied Upon Referencesmentioning
confidence: 99%
“…Reserpine was used as a first-line treatment for hypertension, but after chronic use, severe side effects leading to depression were observed (Guo et al, 2015). Studies have shown that this side effect is caused by the depletion of monoamines such as serotonin, dopamine, and norepinephrine (Gao et al, 2016). This evidence has been applied to animal models showing depressive symptoms, and reserpine-administered animal models are being used to study the pathological symptoms of depression (Uriguen et al, 2008).…”
Section: Introductionmentioning
confidence: 99%